TB-500 vs Thymosin Beta-4
Well Studied vs Well Studied
synergistic TB-500 is the bioactive fragment of Thymosin β4. Combined use provides full-length peptide benefits plus concentrated bioactive effects.
Molecular Data
TB-500 Thymosin Beta-4
Weight 4,963.44 Da 4,963.44 Da
Half-life ~2 hours Dose-dependent; relatively short (exact values not established)
Chain 43 amino acids 43 amino acids
Type Thymosin fragment Thymosin peptide
Key Benefits
TB-500
01 Superior systemic tissue repair
02 Accelerated muscle, tendon, and ligament healing
03 Enhanced cell migration and angiogenesis
04 Comprehensive regenerative effects
05 Neuroprotective properties
Thymosin Beta-4
01 Systemic regenerative effects
02 Proven clinical efficacy
03 Optimal bioavailability for tissue repair
04 Promotes angiogenesis
05 Reduces inflammation
Dosing Protocols
TB-500
2-5mg per injection (higher doses for serious injuries) / 2-3x weekly (e.g., Monday, Wednesday, Friday)
General tissue repair 2-3mg 2x weekly
Serious injury recovery 4-5mg 3x weekly
Athletic enhancement 2-3mg 2x weekly
Chronic conditions 3-4mg 2-3x weekly
Maintenance 2mg 1-2x weekly
Post-surgical recovery 3-5mg 3x weekly
Thymosin Beta-4
2-6mg per injection (varies by protocol and severity) / Daily for acute healing, 2x weekly for maintenance/chronic conditions
Acute Wound Healing 1.6mg Daily
Cardiac Protection 42mg Single dose
Chronic Tissue Repair 6mg Twice weekly
Neurological Recovery 30mg Three times over 72 hours
General Regeneration 2-5mg Daily or every other day
Side Effects
TB-500
Generally minimal side effects
Possible mild injection site reactions
Temporary fatigue in some users
Thymosin Beta-4
Mild injection site reactions
Local inflammation at injection sites
Contraindications
Active cancer treatment (due to angiogenic effects)
Pregnancy or breastfeeding
Immunosuppressive medications (consult provider)
WADA prohibited for competitive athletes
Active chemotherapy treatment
Severe systemic allergies to peptides
Research Evidence
TB-500 Thymosin Beta-4
Status Well Studied Well Studied
References 4 studies 4 studies
Latest March 2024 —
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.